Senior Scientist, Targeted Delivery Biology
Bristol Myers Squibb
Summary
We are seeking a highly motivated and collaborative Senior Scientist, Targeted Delivery Biology to join BMS's Non-Viral Delivery team and help define the next frontier in targeted delivery biology at an exciting inflection point in the field. As part of a dynamic and cross-functional team, you will drive the mechanistic understanding and biological optimization of targeted nanoparticle delivery systems, pushing the boundaries of selective and efficient delivery to unlock therapeutic access into new cell types and tissues. This role sits at the intersection of cell biology, receptor biology, and delivery sciences, representing a rare opportunity to contribute foundationally to a growing platform and work at the cutting edge of non-viral delivery biology to help shape the next generation of targeted therapeutics.
Job description
Position Responsibilities
- Design and apply mechanistic and functional assays to interrogate nanoparticle delivery across key biological barriers, from cellular uptake and endosomal escape to functional payload activity, and translate findings into actionable design principles that guide nanoparticle optimization and next-generation delivery strategies.
- Establish cell-based approaches to identify and validate receptors for targeted delivery, investigating key receptor properties, including expression, accessibility, internalization kinetics, and trafficking, to optimize delivery efficiency and selectivity.
- Contribute to internal and external efforts in receptor identification and targeting-ligand discovery and development to enable targeted delivery into new cell types and tissues.
- Develop and apply in vitro safety and biocompatibility assays to characterize biological responses to nanoparticle delivery systems and support early identification and mitigation of delivery-related liabilities.
- Contribute to the evaluation and assessment of emerging delivery technologies, applying delivery-relevant biological and functional criteria to support platform and lead selection decisions.
- Collaborate effectively across multidisciplinary teams, including formulation and delivery sciences, protein engineering, analytical development, and pharmacology, to translate biological insights into improved delivery platform design.
- Effectively communicate scientific findings and actionable recommendations to multidisciplinary teams and leadership to influence delivery strategy and program decisions.
- Provide scientific mentorship to junior scientists and contribute to the development of new experimental approaches and technologies.
Basic Qualifications
- Bachelor’s Degree 7+ years of academic and / or industry experience
- Or Master’s Degree 5+ years of academic and / or industry experience
- Or Ph.D. or equivalent advanced degree in the Life Sciences 2+ of academic and / or industry experience
Preferred Qualifications
- PhD in Cell Biology, Molecular Biology, Immunology, Biochemistry, Bioengineering, Pharmaceutical Sciences, or a related discipline with 2+ years of relevant industry experience; or MS with 5+ years; or BS with 7+ years of relevant experience.
- Strong background in cell biology and quantitative cell-based assay development, with demonstrated ability to design and apply experiments to address mechanistic biological questions.
- Strong understanding of receptor-mediated delivery, including the key properties that influence productive cellular uptake and delivery.
- Experience developing and applying quantitative and functional cell-based assays across a range of imaging, flow cytometry, molecular biology, and biochemical methods.
- Experience with nanoparticles, lipid nanoparticles, liposomes, extracellular vesicles, biologics, nucleic acid delivery systems, antibody-drug conjugates, or other complex delivery modalities is preferred.
- Demonstrated ability to work effectively in multidisciplinary teams and thrive in a highly collaborative, cross-functional research environment.
- Strong scientific communication skills, with the ability to present complex data and mechanistic insights clearly and compellingly to diverse audiences including project teams and senior leadership.
Requirements
- Bachelor’s Degree with 7+ years of academic and/or industry experience
- Master’s Degree with 5+ years of academic and/or industry experience
- Ph.D. or equivalent advanced degree in the Life Sciences with 2+ years of academic and/or industry experience
- Strong background in cell biology and quantitative cell-based assay development
- Strong understanding of receptor-mediated delivery
- Experience developing and applying quantitative and functional cell-based assays across imaging, flow cytometry, molecular biology, and biochemical methods
- Demonstrated ability to work effectively in multidisciplinary teams
- Strong scientific communication skills
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Time Off
- Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Leaves of Absence
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.